Testing Bofanglutide for Type 2 Diabetes Control
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests a new medication called bofanglutide in adults with type 2 diabetes who are currently taking metformin. The medication works similarly to a hormone that helps control blood sugar, and the study aims to see if it can help lower blood sugar levels and manage weight better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes diagnosed for more than 6 months
- You are currently taking metformin at a stable dose (at least 1500 mg/day or the highest dose you tolerate) with no plans to change it
- Your recent blood sugar control (HbA1c) is between 7.0% and 10.5%
- Your body mass index (BMI) is 27 or higher, and your weight has been stable (no more than 5% change in the past 3 months)
- You have no history of severe thyroid cancer, pancreas problems, or recent severe low blood sugar episodes
- You are willing to use effective contraception if you can become pregnant, and not plan pregnancy for 6 months after the study ends
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares a weekly injection called semaglutide with a calorie-restricted diet to see which helps control blood sugar better. If you have just been diagnosed with type 2 diabetes and have overweight, this trial might help you choose a treatment path.
This trial tests an investigational drug called BGM0504 in people with type 2 diabetes who are already taking metformin or metformin plus another diabetes medicine. It aims to see if the drug can help lower blood sugar levels.
This study tests if starting two newer diabetes drugs (empagliflozin and semaglutide) soon after diagnosis, along with metformin, helps control blood sugar better than metformin alone. It's for people diagnosed with type 2 diabetes in the last two years who are already taking a high dose of metformin.
This trial tests a new medication called PG-102 for people with type 2 diabetes. It compares PG-102 to a placebo (inactive treatment) and semaglutide (a standard diabetes drug) to see if it can help lower blood sugar and potentially help with weight loss.
This study tests if the medication semaglutide helps adults with overweight or obesity lose weight safely. It includes people with or without type 2 diabetes, and aims to see how well the drug works in a Bangladeshi population.
This trial tests if a new form of semaglutide works as well as the approved drug Ozempic for lowering blood sugar. It's for adults with type 2 diabetes who are already taking metformin and need better sugar control.
Hear when a new Type 2 Diabetes Mellitus (T2DM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.